X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13465) 13465
Book Review (2819) 2819
Publication (1720) 1720
Newspaper Article (733) 733
Book / eBook (640) 640
Newsletter (315) 315
Magazine Article (169) 169
Patent (153) 153
Book Chapter (103) 103
Government Document (68) 68
Trade Publication Article (45) 45
Conference Proceeding (37) 37
Report (16) 16
Dissertation (15) 15
Web Resource (7) 7
Transcript (6) 6
Reference (5) 5
Data Set (3) 3
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11146) 11146
humans (6820) 6820
animals (6616) 6616
eye diseases (5999) 5999
ophthalmology (5149) 5149
male (4212) 4212
female (3521) 3521
eye (2881) 2881
sense organs (2742) 2742
genetic structures (2362) 2362
mice (2265) 2265
retina (1883) 1883
rats (1705) 1705
research (1689) 1689
macular degeneration (1577) 1577
middle aged (1557) 1557
adult (1430) 1430
analysis (1371) 1371
medicine (1364) 1364
aged (1344) 1344
research article (1343) 1343
disease models, animal (1320) 1320
care and treatment (1295) 1295
pharmacology & pharmacy (1248) 1248
proteins (1247) 1247
article (1239) 1239
multidisciplinary sciences (1190) 1190
inflammation (1168) 1168
neurosciences (1132) 1132
expression (1120) 1120
surgery (1113) 1113
rabbits (1099) 1099
health aspects (1086) 1086
glaucoma (1031) 1031
physiological aspects (1012) 1012
cell biology (955) 955
rodents (940) 940
science (912) 912
vascular endothelial growth factor (898) 898
mice, inbred c57bl (848) 848
gene expression (839) 839
studies (838) 838
biochemistry & molecular biology (830) 830
cornea (819) 819
abridged index medicus (811) 811
apoptosis (806) 806
medicine, research & experimental (778) 778
disease (773) 773
diabetic retinopathy (737) 737
immunology (732) 732
risk factors (723) 723
endothelial growth-factor (692) 692
cells (691) 691
treatment outcome (690) 690
diabetes (684) 684
diagnosis (683) 683
drug therapy (682) 682
patients (682) 682
oxidative stress (681) 681
eyes (676) 676
review (675) 675
medical research (662) 662
therapy (657) 657
angiogenesis (644) 644
medicine & public health (613) 613
time factors (613) 613
physiology (607) 607
aged, 80 and over (599) 599
eye proteins - metabolism (591) 591
in-vivo (582) 582
age (580) 580
cells, cultured (579) 579
retina - metabolism (577) 577
in-vitro (569) 569
biology (564) 564
genetic aspects (563) 563
drug delivery systems (551) 551
immunohistochemistry (551) 551
cytokines (545) 545
administration, topical (537) 537
drugs (537) 537
degeneration (536) 536
biology and life sciences (534) 534
clinical trials (534) 534
medicine and health sciences (530) 530
neovascularization (529) 529
dose-response relationship, drug (527) 527
usage (527) 527
rats, sprague-dawley (525) 525
cancer (522) 522
intravitreal injections (517) 517
diseases (492) 492
cataracts (488) 488
eye - metabolism (488) 488
mutation (488) 488
animal models (487) 487
eye - drug effects (482) 482
bevacizumab (481) 481
neurons (475) 475
genetics (458) 458
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (564) 564
Collection Dvlpm't (Acquisitions) - Vendor file (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (18) 18
St. Michael's Hospital - Stacks (7) 7
UofT at Mississauga - Stacks (7) 7
Online Resources - Online (6) 6
UTL at Downsview - May be requested (6) 6
Scarborough Hospital - General (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Gerstein Science - Reference (3) 3
Humber River Regional Hospital - Finch Stacks (3) 3
Providence Healthcare - Stacks (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Royal Ontario Museum - Periodical Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
St Josephs Health Centre - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Periodical Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15571) 15571
French (114) 114
German (54) 54
Japanese (24) 24
Spanish (17) 17
Russian (12) 12
Turkish (11) 11
Chinese (7) 7
Arabic (6) 6
Polish (6) 6
Korean (5) 5
Italian (4) 4
Czech (1) 1
Dutch (1) 1
Hungarian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 2017, Volume 292, Issue 45, pp. 18486 - 18499
The cornea is densely innervated to sustain the integrity of the ocular surface. Corneal nerve damage produced by aging, diabetes, refractive surgeries, and... 
EXPERIMENTAL SURGERY | phospholipase A | cornea | BIOCHEMISTRY & MOLECULAR BIOLOGY | brain-derived neurotrophic factor (BDNF) | neuropeptides | SPINAL-CORD | NGF | IDENTIFICATION | SENSORY NEURONS | PEDF | adipose triglyceride lipase | Sema7A | DRY EYE | INFLAMMATION | PEDF PLUS DHA | GROWTH-FACTOR | DHA | C-JUN | lipid signaling | Male | Receptors, Neuropeptide - metabolism | Eye Proteins - agonists | Trigeminal Ganglion - drug effects | Neuroprotective Agents - metabolism | Enzyme Inhibitors - administration & dosage | Nerve Growth Factors - pharmacology | Neuroprotective Agents - pharmacology | Cornea - pathology | Eye Proteins - antagonists & inhibitors | Organ Culture Techniques | Docosahexaenoic Acids - therapeutic use | Trigeminal Ganglion - pathology | Nerve Tissue Proteins - agonists | Trigeminal Nerve Injuries - drug therapy | Enzyme Inhibitors - pharmacology | Injections, Intraperitoneal | Nerve Growth Factors - administration & dosage | Serpins - pharmacology | Nerve Growth Factors - therapeutic use | Eye Proteins - metabolism | Nerve Regeneration - drug effects | Cornea - innervation | Eye Proteins - pharmacology | Neuroprotective Agents - therapeutic use | Administration, Ophthalmic | Cornea - physiology | Cornea - drug effects | Eye Proteins - administration & dosage | Receptors, Neuropeptide - agonists | Eye Proteins - genetics | Drug Therapy, Combination | Neuroprotective Agents - administration & dosage | Trigeminal Ganglion - physiology | Nerve Tissue Proteins - antagonists & inhibitors | Mice, Inbred C57BL | Receptors, Neuropeptide - antagonists & inhibitors | Trigeminal Nerve - pathology | Eye Proteins - therapeutic use | Serpins - therapeutic use | Docosahexaenoic Acids - administration & dosage | Nerve Tissue Proteins - genetics | Serpins - administration & dosage | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Trigeminal Nerve - drug effects | Trigeminal Nerve - physiology | Animals | Phenylurea Compounds - administration & dosage | Phenylurea Compounds - pharmacology | Models, Neurological | Docosahexaenoic Acids - metabolism | Index Medicus | Neurobiology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article
Ophthalmology, ISSN 0161-6420, 10/2015, Volume 122, Issue 10, pp. 2044 - 2052
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2013, Volume 155, Issue 3, pp. 429 - 437.e7
Purpose To evaluate intravitreal aflibercept injections (IAI; also called VEGF Trap-Eye) for patients with macular edema secondary to central retinal vein... 
Ophthalmology | EYE | PHOTOCOAGULATION | OPHTHALMOLOGY | VEGF-TRAP | OUTCOMES | RANIBIZUMAB | Intraocular Pressure - drug effects | Prospective Studies | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Male | Retinal Vein Occlusion - complications | Macular Edema - etiology | Angiogenesis Inhibitors - administration & dosage | Visual Acuity - drug effects | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Recombinant Fusion Proteins - administration & dosage | Retinal Vein Occlusion - physiopathology | Double-Blind Method | Sickness Impact Profile | Tomography, Optical Coherence | Treatment Outcome | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Retinal Vein Occlusion - drug therapy | Macular Edema - physiopathology | Macular Edema - drug therapy | Quality of Life | Aged | Receptors, Vascular Endothelial Growth Factor - adverse effects | Dropsy | Edema | Product development | Consulting services | Vascular endothelial growth factor | Retinal diseases | Macular degeneration | Studies | Diabetic retinopathy | Health Insurance Portability & Accountability Act 1996-US | Clinical trials | Pharmaceuticals | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Nature Communications, ISSN 2041-1723, 03/2017, Volume 8, Issue 1, pp. 14837 - 14837
Journal Article
by Abrams, D and Lévy, Y and Losso, M. H and Babiker, A and Collins, G and Cooper, D. A and Darbyshire, J and Emery, S and Fox, L and Gordin, F and Lane, H. C and Lundgren, J. D and Mitsuyasu, R and Neaton, J. D and Phillips, A and Routy, J. P and Tambussi, G and Wentworth, D and Aagaard, B and Aragon, E and Arnaiz, J and Borup, L and Clotet, B and gsted, U and Fau, A and Gey, D and Grarup, J and Hengge, U and Herrero, P and Jansson, P and Jensen, B and Jensen, K and Juncher, H and Lopez, P and Lundgren, J and Matthews, C and Mollerup, D and Pearson, M and Reilev, S and Tillmann, K and Varea, S and Angus, B and Cordwell, B and Dodds, W and Fleck, S and Horton, J and Hudson, F and Moraes, Y and Pacciarini, F and Palfreeman, A and Paton, N and Smith, N and van Hooff, F and Bebchuk, J and Denning, E and DuChene, A and Fosdick, L and Harrison, M and Herman-Lamin, K and Krum, E and Larson, G and Neaton, J and Nelson, R and Quan, K and Quan, S and Schultz, T and Thompson, G and Wyman, N and Carey, C and Chan, F and Cooper, D and Courtney-Rodgers, D and mmond, F and Harrod, M and Jacoby, S and Kearney, L and Law, M and Lin, E and Pett, S and Robson, R and Seneviratne, N and Stewart, M and Watts, E and Finley, E and Sánchez, A and Stanidge, B and Vjecha, M and Belloso, W and Davey, R and Duprez, D and Gatell, J and Hoy, J and Lifson, A and Pederson, C and Perez, G and Price, R and Prineas, R and Rhame, F and Sampson, J and Worley, J and ... and The INSIGHT–ESPRIT Study Group and SILCAAT Scientific Committee and INSIGHT-ESPRIT Study Grp and SILCAAT Sci Comm and INSIGHT-ESPRIT Study Group and SILCAAT Scientific Committee
The New England Journal of Medicine, ISSN 0028-4793, 10/2009, Volume 361, Issue 16, pp. 1548 - 1559
Journal Article